Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Clinical Significance of Measurable Residual Disease (MRD) in Light-Chain (AL) Amyloidosis

Blood (2024) 144 (Supplement 1): 889.

https://doi.org/10.1182/blood-2024-202995

Published: 2024

Journal Articles

Expanding the Eureka Study: Integrating a Comprehensive Clinical Registry with Molecular Profiling to Advance AL Amyloidosis Research

Blood (2024) 144 (Supplement 1): 1927.1.

https://doi.org/10.1182/blood-2024-200529

Published: 2024

Journal Articles

Bone Marrow-Free Sequencing of M Protein Genes: A Liquid Biopsy Approach in Monoclonal Gammopathies

Alice Nevone, Arian Sadeghi, Giulia Mazzini, Paolo Milani, Silvia Mangiacavalli, Serena Caminito, Francesca Lattarulo, Monica Russo, Giada Panno, Marco Basset, Claudio Salvatore Cartia, Pietro Benvenuti, Martina Nanci, Claudia Bellofiore, Andrea Foli, Giampaolo Merlini, Luca Arcaini, Giovanni O. Palladini, Mario Nuvolone

Blood (2024) 144 (Supplement 1): 6905.

https://doi.org/10.1182/blood-2024-206861

Published: 2024

Journal Articles

Multiomic Characterization of Clonotypic B Cells in Patients with Monoclonal Gammopathies

Blood (2024) 144 (Supplement 1): 1879.

https://doi.org/10.1182/blood-2024-201435

Published: 2024

Journal Articles

Light Chain Amyloidosis Plasma Cells Show Specific Chromatin Accessibility and Transcriptome

Blood (2023) 142 (Supplement 1): 4676.

https://doi.org/10.1182/blood-2023-185614

Published: 2023

Journal Articles

Daratumumab-Based Regimens Versus Cybord in Newly Diagnosed Patients with AL Amyloidosis and IIIb Cardiac Stage: A Matched Case-Control Study

Claudia Bellofiore, Marco Basset, Pietro Benvenuti, Mario Nuvolone, Andrea Foli, Martina Nanci, Gianluigi Guida, Andrea Attanasio, Giampaolo Merlini, Giovanni Palladini, Paolo Milani

Blood (2023) 142 (Supplement 1): 2028.

https://doi.org/10.1182/blood-2023-184681

Published: 2023

Journal Articles

Predictors of Hematologic Complete Response Achievement and Maintenance in Patients with AL Amyloidosis Treated with Non-Transplant Chemotherapy

Paolo Milani, Claudia Bellofiore, Marco Basset, Andrea Foli, Pietro Benvenuti, Francesca Fabris, Martina Nanci, Mario Nuvolone, Giampaolo Merlini, Giovanni Palladini

Blood (2022) 140 (Supplement 1): 7172–7173.

https://doi.org/10.1182/blood-2022-169614

Published: 2022

Journal Articles

Bone Marrow-Free Sequencing of M Protein Genes in Monoclonal Gammopathies

Alice Nevone, Giulia Mazzini, Paolo Milani, Silvia Mangiacavalli, Anna Melati, Giulia Scanavino, Maria Girelli, Serena Caminito, Marco Basset, Claudio Salvatore Cartia, Pietro Benvenuti, Martina Nanci, Claudia Bellofiore, Andrea Foli, Giampaolo Merlini, Luca Arcaini, Giovanni Palladini, Mario Nuvolone

Blood (2022) 140 (Supplement 1): 12431–12433.

https://doi.org/10.1182/blood-2022-168615

Published: 2022

Journal Articles

A FAM46C-Dependent Molecular Circuit Modulates Antibody Synthesis and Proliferation in Plasma Cell Dyscrasias

Enrico Milan, Massimo Resnati, Elena Riva, Mario Nuvolone, Simone Cenci

Blood (2022) 140 (Supplement 1): 857.

https://doi.org/10.1182/blood-2022-162234

Published: 2022

Journal Articles

Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival

Marco Basset, Paolo Milani, Andrea Foli, Mario Nuvolone, Pietro Benvenuti, Martina Nanci, Francesca Fabris, Claudia Bellofiore, Giampaolo Merlini, Giovanni Palladini

Blood (2022) 140 (18): 1964–1971.

https://doi.org/10.1182/blood.2022016348

Published: 2022

Includes: Supplemental data

Journal Articles

Single Molecule Real-Time Sequencing of the M Protein (SMaRT M-Seq): Toward Personalized Medicine Approaches in Monoclonal Gammopathies

Blood (2021) 138 (Supplement 1): 2673.

https://doi.org/10.1182/blood-2021-147227

Published: 2021

Journal Articles

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development

Blood (2021) 138 (17): 1583–1589.

https://doi.org/10.1182/blood.2020009754

Published: 2021

Includes: Supplemental data

Journal Articles

The Italian Medicines Agency Prospective Registry of Bortezomib-Based Treatment in AL Amyloidosis

Giovanni Palladini, MD PhD, Paolo Milani, MDPhD, Simone Celant, Valentina Summa, MD, Giovanni Affronti, Pier Paolo Olimpieri, PhD, Sandra Petraglia, MD, Andrea Foli, MD, Mario Nuvolone, MD PhD, Giampaolo Merlini, MD, Pierluigi Russo, MD PhD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-141563

Published: 2020

Journal Articles

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis

Marco Basset, Irene Defrancesco, Paolo Milani, Mario Nuvolone, Sara Rattotti, Andrea Foli, Silvia Mangiacavalli, Marzia Varettoni, Pietro Benvenuti, Claudio Salvatore Cartia, Marco Paulli, Giampaolo Merlini, Luca Arcaini, Giovanni Palladini

Blood (2020) 135 (4): 293–296.

https://doi.org/10.1182/blood.2019002762

Published: 2020

Journal Articles

Sequential Therapy with Cyclophosphamide, Bortezomib and Dexamethasone Followed By Autologous Stem Cell Transplant Is Safe and Highly Effective in AL Amyloidosis

Marco Basset, MD, Paolo Milani, MD PhD, Andrea Foli, MD, Mario Nuvolone, MD PhD, Jessica Ripepi, Margherita Bozzola, Giampaolo Merlini, MD, Giovanni Palladini, MD PhD

Blood (2019) 134 (Supplement_1): 3312.

https://doi.org/10.1182/blood-2019-130364

Published: 2019

Journal Articles

Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis

Paolo Milani, MD PhD, Francesca Fazio, MD, Marco Basset, MD, Tamara Berno, MD, Alessandra Larocca, Andrea Foli, MD, Marcello Riva, MD, Stefania Oliva, Jessica Ripepi, Mario Nuvolone, MD PhD, Maria Teresa Petrucci, Giampaolo Merlini, MD, Giovanni Palladini, MD PhD

Blood (2019) 134 (Supplement_1): 1860.

https://doi.org/10.1182/blood-2019-130675

Published: 2019

Journal Articles

The Quest for Indicators of Profound Hematologic Response in AL Amyloidosis: Complete Response Remains the Optimal Goal of Therapy

Paolo Milani, MD PhD, Marco Basset, MD, Andrea Foli, MD, Mario Nuvolone, MD PhD, Jessica Ripepi, Margherita Bozzola, Giampaolo Merlini, MD, Giovanni Palladini, MD PhD

Blood (2019) 134 (Supplement_1): 1901.

https://doi.org/10.1182/blood-2019-130378

Published: 2019

Journal Articles

Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients

Masayoshi Tasaki, Paolo Milani, Andrea Foli, Laura Verga, Laura Obici, Marco Basset, Margherita Bozzola, Giovanni Ferraro, Mario Nuvolone, Patrizia Morbini, Gianluca Capello, Mitsuharu Ueda, Konen Obayashi, Marco Paulli, Yukio Ando, Giampaolo Merlini, Giovanni Palladini, Francesca Lavatelli

Blood (2019) 134 (3): 320–323.

https://doi.org/10.1182/blood.2019000420

Published: 2019

Journal Articles

Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis

Giovanni Palladini, Paola Russo, Mario Nuvolone, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Giampaolo Merlini

Blood (2007) 110 (2): 787–788.

https://doi.org/10.1182/blood-2007-02-076034

Published: 2007

Journal Articles

Early Harvest Followed by Melphalan-Dexamethasone and Second-Line Autologous Stem Cell Transplantation in AL Amyloidosis.

Giovanni Palladini, MD, Vittorio Perfetti, MD, Paola Russo, MD, Francesca Lavatelli, MD, Mario Nuvolone, MD, Laura Obici, MD, Giampaolo Merlini, MD

Blood (2006) 108 (11): 5449.

https://doi.org/10.1182/blood.V108.11.5449.5449

Published: 2006

NARROW

Clinical Significance of Measurable Residual Disease (MRD) in Light-Chain (AL) Amyloidosis

Expanding the Eureka Study: Integrating a Comprehensive Clinical Registry with Molecular Profiling to Advance AL Amyloidosis Research

Bone Marrow-Free Sequencing of M Protein Genes: A Liquid Biopsy Approach in Monoclonal Gammopathies

Multiomic Characterization of Clonotypic B Cells in Patients with Monoclonal Gammopathies

Light Chain Amyloidosis Plasma Cells Show Specific Chromatin Accessibility and Transcriptome

Daratumumab-Based Regimens Versus Cybord in Newly Diagnosed Patients with AL Amyloidosis and IIIb Cardiac Stage: A Matched Case-Control Study

Predictors of Hematologic Complete Response Achievement and Maintenance in Patients with AL Amyloidosis Treated with Non-Transplant Chemotherapy

Bone Marrow-Free Sequencing of M Protein Genes in Monoclonal Gammopathies

A FAM46C-Dependent Molecular Circuit Modulates Antibody Synthesis and Proliferation in Plasma Cell Dyscrasias

Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival

Single Molecule Real-Time Sequencing of the M Protein (SMaRT M-Seq): Toward Personalized Medicine Approaches in Monoclonal Gammopathies

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development

The Italian Medicines Agency Prospective Registry of Bortezomib-Based Treatment in AL Amyloidosis

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis

Sequential Therapy with Cyclophosphamide, Bortezomib and Dexamethasone Followed By Autologous Stem Cell Transplant Is Safe and Highly Effective in AL Amyloidosis

Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis

The Quest for Indicators of Profound Hematologic Response in AL Amyloidosis: Complete Response Remains the Optimal Goal of Therapy

Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients

Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis

Early Harvest Followed by Melphalan-Dexamethasone and Second-Line Autologous Stem Cell Transplantation in AL Amyloidosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only